Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The objective of blood screening is to detect markers of infection in order to prevent the release of infected blood and blood components for clinical use.
The global Blood Screening market size is expected to reach US$ 4168.5 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Screening in various end use industries.
The expanding demands from the Blood Bank and Hospital, are propelling Blood Screening market. Reagent, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instrument segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Screening covered in this report include Abbott Laboratories, Abbott, Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomrieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche and Grifols, etc.
The global Blood Screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Blood Screening market, by region:
Global Blood Screening market, Segment by Type:
Global Blood Screening market, by Application
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Blood Screening manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Blood Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Blood Screening Market Overview
1.1 Blood Screening Product Overview
1.2 Blood Screening Market Segment by Type
1.2.1 Reagent
1.2.2 Instrument
1.3 Global Blood Screening Market Size by Type
1.3.1 Global Blood Screening Market Size Overview by Type (2018-2029)
1.3.2 Global Blood Screening Historic Market Size Review by Type (2018-2023)
1.3.3 Global Blood Screening Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Blood Screening Sales Breakdown by Type (2018-2023)
1.4.2 Europe Blood Screening Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Blood Screening Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Blood Screening Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Blood Screening Sales Breakdown by Type (2018-2023)
2 Global Blood Screening Market Competition by Company
2.1 Global Top Players by Blood Screening Sales (2018-2023)
2.2 Global Top Players by Blood Screening Revenue (2018-2023)
2.3 Global Top Players by Blood Screening Price (2018-2023)
2.4 Global Top Manufacturers Blood Screening Manufacturing Base Distribution, Sales Area, Product Type
2.5 Blood Screening Market Competitive Situation and Trends
2.5.1 Blood Screening Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Blood Screening Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Screening as of 2022)
2.7 Date of Key Manufacturers Enter into Blood Screening Market
2.8 Key Manufacturers Blood Screening Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Blood Screening Status and Outlook by Region
3.1 Global Blood Screening Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Blood Screening Historic Market Size by Region
3.2.1 Global Blood Screening Sales in Volume by Region (2018-2023)
3.2.2 Global Blood Screening Sales in Value by Region (2018-2023)
3.2.3 Global Blood Screening Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Blood Screening Forecasted Market Size by Region
3.3.1 Global Blood Screening Sales in Volume by Region (2024-2029)
3.3.2 Global Blood Screening Sales in Value by Region (2024-2029)
3.3.3 Global Blood Screening Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Blood Screening by Application
4.1 Blood Screening Market Segment by Application
4.1.1 Blood Bank
4.1.2 Hospital
4.2 Global Blood Screening Market Size by Application
4.2.1 Global Blood Screening Market Size Overview by Application (2018-2029)
4.2.2 Global Blood Screening Historic Market Size Review by Application (2018-2023)
4.2.3 Global Blood Screening Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Blood Screening Sales Breakdown by Application (2018-2023)
4.3.2 Europe Blood Screening Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Blood Screening Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Blood Screening Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Blood Screening Sales Breakdown by Application (2018-2023)
5 North America Blood Screening by Country
5.1 North America Blood Screening Historic Market Size by Country
5.1.1 North America Blood Screening Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Blood Screening Sales in Volume by Country (2018-2023)
5.1.3 North America Blood Screening Sales in Value by Country (2018-2023)
5.2 North America Blood Screening Forecasted Market Size by Country
5.2.1 North America Blood Screening Sales in Volume by Country (2024-2029)
5.2.2 North America Blood Screening Sales in Value by Country (2024-2029)
6 Europe Blood Screening by Country
6.1 Europe Blood Screening Historic Market Size by Country
6.1.1 Europe Blood Screening Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Blood Screening Sales in Volume by Country (2018-2023)
6.1.3 Europe Blood Screening Sales in Value by Country (2018-2023)
6.2 Europe Blood Screening Forecasted Market Size by Country
6.2.1 Europe Blood Screening Sales in Volume by Country (2024-2029)
6.2.2 Europe Blood Screening Sales in Value by Country (2024-2029)
7 Asia-Pacific Blood Screening by Region
7.1 Asia-Pacific Blood Screening Historic Market Size by Region
7.1.1 Asia-Pacific Blood Screening Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Blood Screening Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Blood Screening Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Blood Screening Forecasted Market Size by Region
7.2.1 Asia-Pacific Blood Screening Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Blood Screening Sales in Value by Region (2024-2029)
8 Latin America Blood Screening by Country
8.1 Latin America Blood Screening Historic Market Size by Country
8.1.1 Latin America Blood Screening Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Blood Screening Sales in Volume by Country (2018-2023)
8.1.3 Latin America Blood Screening Sales in Value by Country (2018-2023)
8.2 Latin America Blood Screening Forecasted Market Size by Country
8.2.1 Latin America Blood Screening Sales in Volume by Country (2024-2029)
8.2.2 Latin America Blood Screening Sales in Value by Country (2024-2029)
9 Middle East and Africa Blood Screening by Country
9.1 Middle East and Africa Blood Screening Historic Market Size by Country
9.1.1 Middle East and Africa Blood Screening Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Blood Screening Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Blood Screening Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Blood Screening Forecasted Market Size by Country
9.2.1 Middle East and Africa Blood Screening Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Blood Screening Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Laboratories Blood Screening Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Abbott
10.2.1 Abbott Company Information
10.2.2 Abbott Introduction and Business Overview
10.2.3 Abbott Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Blood Screening Products Offered
10.2.5 Abbott Recent Development
10.3 Apex Biotechnology Corp.
10.3.1 Apex Biotechnology Corp. Company Information
10.3.2 Apex Biotechnology Corp. Introduction and Business Overview
10.3.3 Apex Biotechnology Corp. Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Apex Biotechnology Corp. Blood Screening Products Offered
10.3.5 Apex Biotechnology Corp. Recent Development
10.4 Beckman Coulter (A Subsidiary of Danaher Corporation)
10.4.1 Beckman Coulter (A Subsidiary of Danaher Corporation) Company Information
10.4.2 Beckman Coulter (A Subsidiary of Danaher Corporation) Introduction and Business Overview
10.4.3 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Products Offered
10.4.5 Beckman Coulter (A Subsidiary of Danaher Corporation) Recent Development
10.5 Becton, Dickinson and Company
10.5.1 Becton, Dickinson and Company Company Information
10.5.2 Becton, Dickinson and Company Introduction and Business Overview
10.5.3 Becton, Dickinson and Company Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Becton, Dickinson and Company Blood Screening Products Offered
10.5.5 Becton, Dickinson and Company Recent Development
10.6 Biomrieux
10.6.1 Biomrieux Company Information
10.6.2 Biomrieux Introduction and Business Overview
10.6.3 Biomrieux Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Biomrieux Blood Screening Products Offered
10.6.5 Biomrieux Recent Development
10.7 Bio-Rad Laboratories, Inc.
10.7.1 Bio-Rad Laboratories, Inc. Company Information
10.7.2 Bio-Rad Laboratories, Inc. Introduction and Business Overview
10.7.3 Bio-Rad Laboratories, Inc. Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bio-Rad Laboratories, Inc. Blood Screening Products Offered
10.7.5 Bio-Rad Laboratories, Inc. Recent Development
10.8 F. Hoffmann-La Roche
10.8.1 F. Hoffmann-La Roche Company Information
10.8.2 F. Hoffmann-La Roche Introduction and Business Overview
10.8.3 F. Hoffmann-La Roche Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.8.4 F. Hoffmann-La Roche Blood Screening Products Offered
10.8.5 F. Hoffmann-La Roche Recent Development
10.9 Grifols
10.9.1 Grifols Company Information
10.9.2 Grifols Introduction and Business Overview
10.9.3 Grifols Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Grifols Blood Screening Products Offered
10.9.5 Grifols Recent Development
10.10 Hem
10.10.1 Hem Company Information
10.10.2 Hem Introduction and Business Overview
10.10.3 Hem Blood Screening Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Hem Blood Screening Products Offered
10.10.5 Hem Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Blood Screening Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Blood Screening Industrial Chain Analysis
11.4 Blood Screening Market Dynamics
11.4.1 Blood Screening Industry Trends
11.4.2 Blood Screening Market Drivers
11.4.3 Blood Screening Market Challenges
11.4.4 Blood Screening Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Blood Screening Distributors
12.3 Blood Screening Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research